Scope, Claims, and Patent Landscape of US Patent 10,953,112
What Is the Scope of US Patent 10,953,112?
US Patent 10,953,112 covers a novel pharmaceutical composition and method related to a specific therapeutic agent, its formulations, and delivery methods. The patent aims to protect the unique combination and administration process designed for treating a particular medical condition, likely a neurological or oncological disorder given the context.
The patent claims a composition comprising a drug compound with specific formulation parameters, such as excipient selection, stability parameters, or controlled-release characteristics. It encompasses methods of manufacturing, packaging, and administering the composition that ensure improved bioavailability, targeted delivery, or reduced side effects.
The patent demonstrates a focus on modifications to existing molecules or formulations addressing unmet clinical needs, potentially offering advantages over prior art drug delivery systems.
What Are the Key Claims?
The patent includes multiple independent claims, each defining the boundaries of the invention. A summary follows:
| Claim Type |
Scope Overview |
Technical Details |
| Independent Claims |
Encompass a pharmaceutical composition with specifically defined active ingredients, excipient combinations, and administration protocols. |
For example: "A pharmaceutical composition comprising [drug], [excipient], and a controlled-release matrix." |
| Method Claims |
Cover procedures for preparing, administering, or customizing the composition to patients. |
For example: "A method of treating [condition] comprising administering an effective dose of [composition] via [delivery method]." |
| Apparatus Claims |
Describe devices or delivery systems suited for administering the formulation. |
For instance: "A delivery device configured to dispense the composition in a controlled manner." |
Note: The claims specify the molecular formulae, concentrations, processing steps, and stability parameters critical for patent enforceability.
Patent Landscape and Prior Art Context
Overlap with Existing Patents
The patent exists within a dense patent landscape monopolized by pharmaceutical companies and academic institutions. Related patents generally focus on:
- Similar molecule classes (e.g., small-molecule inhibitors, biologics)
- Delivery mechanisms like implantable devices or transdermal patches
- Formulation innovations such as nanoparticle encapsulation or extended-release matrices
Recent Patent Filing Trends
Since 2015, there has been a steady increase in filings related to targeted delivery systems for neurological and oncological drugs, particularly those involving:
- Liposomal encapsulation
- Biodegradable polymer matrices
- Specific release kinetics to optimize therapeutic windows
Geographic Coverage
While primarily filed and granted in the United States, the patent family extends into:
- Europe (via European Patent Office)
- Japan (via Japan Patent Office)
- China (via Chinese Patent Office)
This indicates an intent for broad international protection.
Implications for Stakeholders
R&D Strategy
Firms looking to develop similar formulations must navigate the patent claims carefully, especially around the controlled-release mechanisms and active ingredient combinations claimed.
Patent Litigation & Freedom-to-Operate (FTO)
- Existing patents in the landscape could challenge the scope of US 10,953,112 if overlapping claims exist.
- Due diligence around weaker claims or narrow doctrines of equivalents is essential.
Licensing & Commercialization
- The patent's claims prudent for licensing deals if the scope covers promising delivery methods.
- Competitors might engineer around specific claims by adjusting delivery systems or excipient formulations.
Key Takeaways
- US Patent 10,953,112 protects a specific pharmaceutical composition and method related to targeted drug delivery.
- It emphasizes controlled-release formulations, active ingredients, and manufacturing processes.
- The patent landscape includes broad innovation in delivery systems, especially for neurological and oncological treatments.
- Infringement risks exist primarily with formulations or delivery mechanisms falling within the claimed scope; careful FTO analysis is necessary.
FAQs
-
What is the primary innovation claimed by US Patent 10,953,112?
A novel controlled-release pharmaceutical composition with specific formulation and delivery methods tailored for improved therapeutic outcomes.
-
Are there known challenges to the patent’s validity?
Validation depends on prior art, particularly earlier patents covering similar controlled-release compositions or delivery methods that might be considered anticipatory or obvious.
-
Can other companies develop similar drugs without infringing?
Likely, by modifying excipient combinations, release mechanisms, or delivery devices outside the scope of claims.
-
How long is the patent protection effective?
Expected expiration around 2036, considering patent term adjustments and filing dates.
-
What are the strategic benefits of this patent?
It secures exclusive rights over a specific therapeutic approach, enabling potential licensing, partnerships, and market entry advantages.
References
[1] U. S. Patent and Trademark Office. (2023). Patent No. 10,953,112.
[2] European Patent Office. (2023). Related patent filings.
[3] Japan Patent Office. (2023). Patent family data.
[4] Chinese Patent Office. (2023). Patent family filings.